Cited by 1,139Dementia and Cognitive Impairment ResearchNeuroinflammation and Neurodegeneration MechanismsAlzheimer's disease research and treatments

The DOI matches its Crossref record; 40 of the 42 references it cites were found in a registry or an index.

Systemic inflammation and disease progression in Alzheimer disease

Open access

Holmes, C., Cunningham, C., Zotova, E., Woolford, J., Dean, C., Kerr, S., Culliford, D., Perry, V. H.·2009·Neurology

DOI 10.1212/wnl.0b013e3181b6bb95PMC PMC2848584

Open this paper in CoChat — free account

Abstract

BACKGROUND: Acute and chronic systemic inflammation are characterized by the systemic production of the proinflammatory cytokine tumor necrosis factor alpha (TNF-alpha) that plays a role in immune to brain communication. Previous preclinical research shows that acute systemic inflammation contributes to an exacerbation of neurodegeneration by activation of primed microglial cells. OBJECTIVE: To determine whether acute episodes of systemic inflammation associated with increased TNF-alpha would be associated with long-term cognitive decline in a prospective cohort study of subjects with Alzheimer disease. METHODS: Three hundred community-dwelling subjects with mild to severe Alzheimer disease were cognitively assessed, and a blood sample was taken for systemic inflammatory markers. Each subject's main caregiver was interviewed to assess the presence of incident systemic inflammatory events. Assessments of both patient and caregiver were repeated at 2, 4, and 6 months. RESULTS: Acute systemic inflammatory events, found in around half of all subjects, were associated with an increase in the serum levels of proinflammatory cytokine TNF-alpha and a 2-fold increase in the rate of cognitive decline over a 6-month period. High baseline levels of TNF-alpha were associated with a 4-fold increase in the rate of cognitive decline. Subjects who had low levels of serum TNF-alpha throughout the study showed no cognitive decline over the 6-month period. CONCLUSIONS: Both acute and chronic systemic inflammation, associated with increases in serum tumor necrosis factor alpha, is associated with an increase in cognitive decline in Alzheimer disease.

Integrity signals

Registry

Crossref · 10.1212/wnl.0b013e3181b6bb95

Cites

40 of 40 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Clinical diagnosis of Alzheimer's disease: Report of the NINCDS‐ADRDA Work Group* under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915
Special Care Units and Traditional Care in Dementia: Relationship with Behavior, Cognition, Functional Status and Quality of Life - A Review
Kok, J. S., Berg, I. J., & Scherder, E. J. A. (2013) · Dementia and Geriatric Cognitive Disorders Extra · doi:10.1159/000353441 · Cited by 20,589
Markers of Inflammation and Cardiovascular Disease: Application to Clinical and Public Health Practice: A Statement for Healthcare Professionals From the Centers for Disease Control and Prevention and the American Heart Association
Pearson, T. A., Mensah, G. A., Alexander, R. W., Anderson, J. L., Cannon, R. O., Criqui, M., Fadl, Y. Y., Fortmann, S. P., Hong, Y., Myers, G. L., et al. (2003) · Circulation · doi:10.1161/01.cir.0000052939.59093.45 · Cited by 6,401
Clarifying Confusion: The Confusion Assessment Method: A New Method for Detection of Delirium
Inouye, S. K., van Dyck, C. H., Alessi, C. A., Balkin, S., Siegal, A. P., & Horwitz, R. I. (1990) · Annals of Internal Medicine · doi:10.7326/0003-4819-113-12-941 · Cited by 5,250
A new rating scale for Alzheimer's disease
(1984) · American Journal of Psychiatry · doi:10.1176/ajp.141.11.1356 · Cited by 4,175
MARKERS OF INFLAMMATION AND CARDIOVASCULAR DISEASE: APPLICATION TO CLINICAL AND PUBLIC HEALTH PRACTICE: A STATEMENT FOR HEALTHCARE PROFESSIONALS FROM THE CENTERS FOR DISEASE CONTROL AND PREVENTION AND THE AMERICAN HEART ASSOCIATION
PearsonT, A., MensahG, A., & AlexanderR, W. (2003) · Journal of Cardiopulmonary Rehabilitation · doi:10.1097/00008483-200305000-00016 · Cited by 2,937
Control of Synaptic Strength by Glial TNFα
Beattie, E. C., Stellwagen, D., Morishita, W., Bresnahan, J. C., Ha, B. K., Von Zastrow, M., Beattie, M. S., & Malenka, R. C. (2002) · Science · doi:10.1126/science.1067859 · Cited by 1,344
Advances in Male Contraception
Page, S. T., Amory, J. K., & Bremner, W. J. (2008) · Endocrine Reviews · doi:10.1210/er.2007-0041 · Cited by 1,138
Classification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteins
Ray, S., Britschgi, M., Herbert, C., Takeda-Uchimura, Y., Boxer, A., Blennow, K., Friedman, L. F., Galasko, D. R., Jutel, M., Karydas, A., et al. (2007) · Nature Medicine · doi:10.1038/nm1653 · Cited by 1,048
Systemic infections and inflammation affect chronic neurodegeneration
Perry, V. H., Cunningham, C., & Holmes, C. (2007) · Nature Reviews Immunology · doi:10.1038/nri2015 · Cited by 1,027
Self-citation

Show all 42 references

Sorted by citations

Items 601–700 of 1,000

APOE4, Alzheimer’s and periodontal disease: A scoping review
Arévalo‐Caro, C., Retana, M. A., Amaya, S. I. L., Arboleda, H., Gallart‐Palau, X., & Serra, A. (2025) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102649 · Cited by 22
Increasing Tau 4R Tau Levels Exacerbates Hippocampal Tau Hyperphosphorylation in the hTau Model of Tauopathy but Also Tau Dephosphorylation Following Acute Systemic Inflammation
Barron, M. R., Gartlon, J. E., Dawson, L. A., Atkinson, P. J., & Pardon, M. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00293 · Cited by 19
“Moreover, systemic infections accelerate the rate of cognitive decline in AD patients, even after the resolution of the initial inflammatory insult (30, 31).”
Background
Role of Cytokines in Chemotherapy-related Cognitive Impairment of Breast Cancer Patients: A Systematic Review
Khan, M. A., Tyagi, K., Masoom, M., Majid, H., Garg, A., Bhurani, D., & Agarwal, N. B. (2022) · Current Clinical Pharmacology · doi:10.2174/2772432817666220304212456 · Cited by 20
Characterization of neural mechanotransduction response in human traumatic brain injury organoid model
Beltrán, S. M., Bobo, J., Habib, A., Kodavali, C. V., Edwards, L., Mamindla, P., Taylor, R. E., LeDuc, P. R., & Zinn, P. O. (2023) · Scientific Reports · doi:10.1038/s41598-023-40431-y · Cited by 25
“Evidence shows that TBI can trigger similar inflammatory responses in the brain 17–19 .”
Receptor–ligand interaction controls microglial chemotaxis and amelioration of Alzheimer's disease pathology
Lau, S., Fu, A. K. Y., & Ip, N. Y. (2023) · Journal of Neurochemistry · doi:10.1111/jnc.15933 · Cited by 21
Elevated CRP and TNF-α levels are associated with blunted neural oscillations serving fluid intelligence
Dietz, S. M., Schantell, M. D., Spooner, R. K., Sandal, M. E., Mansouri, A., Arif, Y., Okelberry, H. J., John, J. A., Glesinger, R. J., May, P. E., et al. (2023) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2023.09.012 · Cited by 20
“…CRP and TNF-α levels to systemic inflammatory disease states as seen in aging, Alz-heimer ’ s disease, Parkinson ’ s disease, and HIV-infection (Hirsch and Hunot 2009; Roberts et al. 2009; Holmes et al. 2009; Noble et al. 2010; Tegeler et al. 2016; Becher et al. 2017; Spooner et al. 2021).”
Additive Microglia-Mediated Neuronal Injury Caused by Amyloid-β and Bacterial TLR Agonists in Murine Neuron-Microglia Co-Cultures Quantified by an Automated Image Analysis using Cognition Network Technology
Schütze, S., Loleit, T., Zeretzke, M., Bunkowski, S., Brück, W., Ribes, S., & Nau, R. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-120856 · Cited by 20
Central delivery of iodine-125–labeled cetuximab, etanercept and anakinra after perispinal injection in rats: possible implications for treating Alzheimer’s disease
Roerink, M. E., Groen, R. J. M., Franssen, G. M., de Weem, B. L.-V., Boerman, O. C., & van der Meer, J. W. M. (2015) · Alzheimer s Research & Therapy · doi:10.1186/s13195-015-0149-7 · Cited by 20
“It plays an important role in immune-to-brain communication [5], and increased TNF-α is associated with rapid neurocognitive decline [6] and neuropsychiatric symptoms [7] in * Correspondence: megan.”
Cerebral magnetic resonance imaging in quiescent Crohn’s disease patients with fatigue
van Erp, S. J. H., Ercan, E., Breedveld, P., Brakenhoff, L., Ghariq, E., Schmid, S., van Osch, M. J. P., van Buchem, M. A., Emmer, B. J., van der Grond, J., et al. (2017) · World Journal of Gastroenterology · doi:10.3748/wjg.v23.i6.1018 · Cited by 21
Diaphanous 1 (DIAPH1) is Highly Expressed in the Aged Human Medial Temporal Cortex and Upregulated in Myeloid Cells During Alzheimer’s Disease
Derk, J., Bermudez‐Hernandez, K., Rodriguez, M., He, M., Koh, H., Abedini, A., Li, H., Fenyö, D., & Schmidt, A. M. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-180088 · Cited by 21
Soluble Fibrinogen Triggers Non-cell Autonomous ER Stress-Mediated Microglial-Induced Neurotoxicity
Piers, T. M., East, E., Villegas-Llerena, C., Sevastou, I. G., Matarín, M., Hardy, J., & Pocock, J. M. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00404 · Cited by 20
“Interestingly elevated systemic fibrinogen, TNFα and IL-6 in mid-life have also been linked with brain shrinkage, cognitive decline, and AD in later life (Marsland et al., 2008; Holmes et al., 2009).”
Background
Association between high levels of inflammatory markers and cognitive outcomes at 4 years of age: The Rhea mother-child cohort study, Crete, Greece
Kyriklaki, A., Margetaki, K., Kampouri, M., Koutra, K., Bitsios, P., Chalkiadaki, G., Dermitzaki, E., Venihaki, M., Sarri, K. O., Anousaki, D., et al. (2019) · Cytokine · doi:10.1016/j.cyto.2019.01.010 · Cited by 20
The Association Between Circulating Inflammatory Markers and the Progression of Alzheimer Disease in Norwegian Memory Clinic Patients With Mild Cognitive Impairment or Dementia
Hazen, J., Vistnes, M., Barca, M. L., Eldholm, R. S., Persson, K., Brækhus, A., Saltvedt, I. T., Selbæk, G., Engedal, K., & Knapskog, A. (2019) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0000000000000342 · Cited by 20
The role of transglutaminase 2 in mediating glial cell function and pathophysiology in the central nervous system
Rudlong, J., Cheng, A., & Johnson, G. V. W. (2019) · Analytical Biochemistry · doi:10.1016/j.ab.2019.113556 · Cited by 20
Effects of chronic hypoxia on the expression of seladin-1/Tuj1 and the number of dark neurons of hippocampus
Mahakizadeh, S., Mokhtari, T., Navaee, F., Poorhassan, M., Tajik, A., & Hassanzadeh, G. (2020) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2020.101744 · Cited by 20
AMBAR, an Encouraging Alzheimer's Trial That Raises Questions
Loeffler, D. A. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.00459 · Cited by 20
“Reduced Inflammation Chronic systemic inflammation has been associated with increased risk for development (68) and progression (69) of AD.”
Background
Association between dementia and systemic rheumatic disease: A nationwide population-based study
Park, H., Yim, D., Ochirpurev, B., Eom, S., Choi, I. A., Ju, G., & Kim, J. H. (2021) · PLoS ONE · doi:10.1371/journal.pone.0248395 · Cited by 20
Microglia
Perry, V. H. (2016) · Microbiology Spectrum · doi:10.1128/microbiolspec.mchd-0003-2015 · Cited by 21
Self-citation
Effects of collagen-induced rheumatoid arthritis on amyloidosis and microvascular pathology in APP/PS1 mice
Park, S. M., Shin, J. H., Moon, G. J., Cho, S. I., Lee, Y. B., & Gwag, B. J. (2011) · BMC Neuroscience · doi:10.1186/1471-2202-12-106 · Cited by 19
“Levels of inflammatory mediators including TNF-a and C-reactive protein (CRP) are also increased in the peripheral blood of AD patients [5,6] and associated with increased risk of AD [7,8].”
Minocycline May Be Useful to Prevent/Treat Postoperative Cognitive Decline in Elderly Patients
Fan, L., Wang, T.-L., Xu, Y. C., Ma, Y. H., & Ye, W. G. (2011) · Medical Hypotheses · doi:10.1016/j.mehy.2011.02.010 · Cited by 19
“Acute systemic inflammatory events associated with elevated serum TNF-alpha such as infection (less than 2 months’ duration) or trauma accelerates disease progression in AD [14].”
Background
Evaluating Mechanisms of Postoperative Delirium and Cognitive Dysfunction Following Elective Spine Surgery in Elderly Patients (CONFESS): Protocol for a Prospective Observational Trial
Müller, J., Nowak, S., Dewey, M., Vogelgesang, A., von Sarnowski, B., Rathmann, E., Schmidt, S., Sebastian, R., Usichenko, T. I., Kertscho, H., et al. (2020) · JMIR Research Protocols · doi:10.2196/15488 · Cited by 20
“Possible reasons for this discrepancy are that some studies included cases of intensive care unit (ICU) delirium, concentrations of markers of inflammation vary substantially between types of surgery [30,92], and neuroinflammatory effects seem to depend on the extent of preexisting neurodegeneration, which was rarely…”
Background
Alterations in T-Cell Transcription Factors and Cytokine Gene Expression in Late-Onset Alzheimer’s Disease
Neshan, M., Malakouti, S. K., Kamalzadeh, L., Makvand, M., Campbell, A., & Ahangari, G. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-210480 · Cited by 19
Gastrointestinal Changes and Alzheimer's Disease
Sohrabi, M., Sahu, B., Kaur, H., Hasler, W. A., Prakash, A. K., & Combs, C. K. (2022) · Current Alzheimer Research · doi:10.2174/1567205019666220617121255 · Cited by 18
Microglia activation and inflammation in hippocampus attenuates memory and mood functions during experimentally induced diabetes in rat
Nagayach, A., Bhaskar, R., & Patro, I. K. (2022) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2022.102160 · Cited by 18
The Innate and Adaptive Immune Cells in Alzheimer’s and Parkinson’s Diseases
Huang, B., Zhenxin, Y., Chen, S., Tan, Z., Zong, Z., Zhang, H., & Xiong, X. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/1315248 · Cited by 19
“Recently, it has also been demonstrated that both innate and adaptive immune cells from the periphery can penetrate through the blood-brain barrier (BBB) into the CNS and thus involved in the neuroinflammation [18, 19].”
Background
TNF-α Levels Are Increased in Patients with Subjective Cognitive Impairment and Are Negatively Correlated with β Amyloid-42
Serafini, S., Ferretti, G., Monterosso, P., Angiolillo, A., Costanzo, A. D., & Matrone, C. (2024) · Antioxidants · doi:10.3390/antiox13020216 · Cited by 19
Reevaluating the Microbial Infection Link to Alzheimer’s Disease
Schnaider, L., Arnon, Z. A., & Gazit, E. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-190765 · Cited by 19
Inflammation/bioenergetics-associated neurodegenerative pathologies and concomitant diseases: a role of mitochondria targeted catalase and xanthophylls
Filippov, M. A., Tatarnikova, O. G., Pozdnyakova, N. V., & Vorobyov, V. (2020) · Neural Regeneration Research · doi:10.4103/1673-5374.290878 · Cited by 21
“They are used for the photosynthesis where the xanthophylls and carotenoids are an integral part of the centers associated with chlorophyll (Horton and Ruban, 2005).”
Background
Reactive Oxygen Species in Neurodegenerative Diseases: Implications in Pathogenesis and Treatment Strategies
Oladele, J. O., Oladiji, A. T., Oladele, O. T., & Oyeleke, O. M. (2021) · Biochemistry · doi:10.5772/intechopen.99976 · Cited by 21
Physiologic Dysfunction Scores and Cognitive Function Test Performance in US Adults
Kobrosly, R. W., Seplaki, C. L., Jones, C. M. C., & van Wijngaarden, E. (2011) · Psychosomatic Medicine · doi:10.1097/psy.0b013e3182385b1e · Cited by 19
“, elevated body mass index, history of diabetes) (9,10), prior history of stroke (2), elevated level of systemic inflammation (3,5), and decreased kidney and liver function (1,4,7,8) have all been associated with lower level of cognitive performance in older adults.”
Background
Risk factors for Alzheimer disease
Dartigues, J., & Féart, C. (2011) · Neurology · doi:10.1212/wnl.0b013e31822550af · Cited by 20
The Association between Adverse Childhood Experiences and Frailty: A Systematic Review
Tao, Y., Wang, H., Luo, J., Zhang, H., Zhang, W., Yu, M., Ji, S., Peng, S., & Zhang, X. (2024) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2024.105042 · Cited by 18
Key biomarkers in Alzheimer’s disease: Insights for diagnosis and treatment strategies
Jamal, R., Shaikh, M. A., Taleuzzaman, M., Haque, Z., Albratty, M., Alam, M. S., Makeen, H. A., Zoghebi, K. A., & Saleh, S. F. (2025) · Journal of Alzheimer s Disease · doi:10.1177/13872877251330500 · Cited by 19
Human Induced Pluripotent Stem Cells and the Modelling of Alzheimer’s Disease: The Human Brain Outside the Dish
Tong, G., Izquierdo, P., & Raashid, R. A. (2017) · The Open Neurology Journal · doi:10.2174/1874205x01711010027 · Cited by 18
“[88] Holmes C, Cunningham C, Zotova E, et al.”
Background
The Neurocognitive Effects of Cannabis Across the Lifespan
Ellingson, J. M., Hinckley, J. D., Ross, J. M., Schacht, J. P., Bidwell, L. C., Bryan, A. D., Hopfer, C. J., Riggs, P., & Hutchison, K. E. (2021) · Current Behavioral Neuroscience Reports · doi:10.1007/s40473-021-00244-7 · Cited by 20
Decreased Netrin-1 in Mild Cognitive Impairment and Alzheimer’s Disease Patients
Ju, T., Sun, L., Fan, Y., Wang, T., Liu, Y., Liu, D., Liu, T., Zhao, C. W., Wang, W., & Chi, L. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.762649 · Cited by 18
Immune Response at the Crossroads of Atherosclerosis and Alzheimer's Disease
Stahr, N. A., & Galkina, E. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.870144 · Cited by 18
“Increased levels of TNFα are also associated with a 2-fold increase in the rate of cognitive decline over a 6-month period (32).”
Background
Soluble TNF mediates amyloid-independent, diet-induced alterations to immune and neuronal functions in an Alzheimer’s disease mouse model
MacPherson, K. P., Eidson, L. N., Houser, M. C., Weiss, B. E., Gollihue, J. L., Herrick, M. K., Rodrigues, M. E. D. S., Sniffen, L. J., Weekman, E. M., Hamilton, A. M., et al. (2023) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2023.895017 · Cited by 19
Postmortem Brains from Subjects with Diabetes Mellitus Display Reduced GLUT4 Expression and Soma Area in Hippocampal Neurons: Potential Involvement of Inflammation
Yonamine, C. Y., Passarelli, M., Suemoto, C. K., Pasqualucci, C. A., Filho, W. J., Alves, V. A. F., Marie, S. K. N., Corrêa‐Giannella, M. L., Britto, L. R., & Machado, U. F. (2023) · Cells · doi:10.3390/cells12091250 · Cited by 18
“In humans with mild to severe AD, high serum levels of TNF are associated with a twofold increase in the rate of cognitive decline over six months [45]; although, this association has not been observed in other studies [46].”
Result
Peripheral HMGB1 is linked to O3 pathology of disease‐associated astrocytes and amyloid
Ahmed, C., Greve, H. J., Garza-Lombó, C., Malley, J. A., Johnson, J., Oblak, A. L., & Block, M. L. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.13825 · Cited by 18
“Increasing evidence suggests that peripheral and systemic immune mechanisms contribute to AD pathobiology; 29,56 for example, periph-eralmyeloidcellsareimplicatedinADandamyloidpathology.”
Background
Increased Risk of Dementia Among Patients With Pulmonary Tuberculosis
Peng, Y., Chen, C., Su, C.-H., Muo, C., Chen, K.-F., Liao, W.-C., & Kao, C. (2015) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/1533317515577186 · Cited by 18
“Moreover, in a cohort study involving 300 community-dwelling patients with mild to severe AD, both acute and chronic systemic inflammation—which are associated with increases in serum TNF-a—were associated with an increase in cognitive decline over a 6-month period.(18) A case–control study by Dunn et al showed that e…”
Background
Fetal thymus graft enables recovery from age-related hearing loss and expansion of CD4-Positive T cells expressing IL-1 receptor type 2 and regulatory T Cells
Iwai, H., & Inaba, M. (2015) · Immunity & Ageing · doi:10.1186/s12979-015-0053-9 · Cited by 18
“Both acute and chronic systemic inflammation is associated with an increase in cognitive decline in Alzheimer’s disease [11].”
Background
Accelerated brain ageing in sepsis survivors with cognitive long‐term impairment
Seidel, G., Gaser, C., Götz, T., Günther, A., & Hamzei, F. (2020) · European Journal of Neuroscience · doi:10.1111/ejn.14850 · Cited by 19
“The brain atrophy could be triggered by the systemic inflammation process which is considered to play a prominent role in progression of neurodegeneration (Cunningham, 2013; DeLegge & Smoke, 2008; Gunther et al., 2012; Holmes et al., 2009; Pandharipande et al., 2013; Shah et al., 2013).”
Background
Amyloid-β1-40 differentially stimulates proliferation, activation of oxidative stress and inflammatory responses in male and female hippocampal astrocyte cultures
Lennol, M. P., Canelles, S., Guerra-Cantera, S., Argente, J., García‐Segura, L. M., CEBALLOS, M. L. D., Chowen, J. A., & Frago, L. M. (2021) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2021.111462 · Cited by 18
Cognitive impairment in syphilis: Does treatment based on cerebrospinal fluid analysis improve outcome?
Davis, A. P., Maxwell, C. L., Mendoza, H., Crooks, A., Dunaway, S. B., Storey, S., Stevens, C. E., Tantalo, L. C., Sahi, S. K., Robertson, K. R., et al. (2021) · PLoS ONE · doi:10.1371/journal.pone.0254518 · Cited by 18
Alzheimer's disease: Is there a role for galectins?
da Rosa, M. M., Ferreira, M. D. A., Lima, C. A. D. O., Mendonça, A. C. S., Silva, Y. M., Sharjeel, M., Rêgo, M. J. B. D. M., Pereira, M. C., & Pitta, M. G. D. R. (2021) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2021.174437 · Cited by 17
The Inflammatory Nature of Post-surgical Delirium Predicts Benefit of Agents With Anti-TNF Effects, Such as Dexmedetomidine
Clark, I. A., & Vissel, B. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00257 · Cited by 17
“, 1993), we could expect excess circulating TNF to contribute to cognitive dysfunction (Holmes et al., 2009).”
Background
Inflammation and Late-Life Depression: Unraveling the Complex Relationship and Potential Therapeutic Strategies
Xia, J., Chen, M., Shao, H., Chen, H., Zhu, S., Zhao, M., Luo, W., Yang, J., & Wu, S. (2023) · Frontiers in Bioscience-Landmark · doi:10.31083/j.fbl2812356 · Cited by 17
“These inflammatory agents can penetrate the central nervous system either through the circulatory system or by crossing the blood-brain barrier, thereby initiating a neuroinflammatory response [121].”
Background
Cholesterol and Copper Affect Learning and Memory in the Rabbit
Schreurs, B. G. (2013) · International Journal of Alzheimer s Disease · doi:10.1155/2013/518780 · Cited by 16
“There is also a growing awareness of the effects of inflammation on cognitive decline [141–144].”
Mechanisms of association between physical functioning and breast cancer mortality: evidence from the Women’s Healthy Eating and Living Study
Marinac, C. R., Patterson, R. E., Villaseñor, A., Flatt, S. W., & Pierce, J. P. (2014) · Journal of Cancer Survivorship · doi:10.1007/s11764-013-0334-2 · Cited by 17
“Inflammation may also contribute to the development of other co-morbid conditions, such as cardiovascular disease [30], Alzheimer’s disease [31], and other cancers [32].”
Background
Neurotoxicology of Metals
Lucchini, R. G., Aschner, M., Bellinger, D. C., & Caito, S. W. (2014) · Elsevier eBooks · doi:10.1016/b978-0-444-59453-2.00015-9 · Cited by 18
Associations between inflammatory markers, candidate polymorphisms and physical performance in older Danish twins
Tiainen, K., Thinggaard, M., Jylhä, M. K., Bladbjerg, E., Christensen, K., & Christiansen, L. (2011) · Experimental Gerontology · doi:10.1016/j.exger.2011.11.002 · Cited by 17
“, 2007), Alzheimer disease (Holmes et al., 2009), osteoporosis (McCormick, 2007), and also with mortality and shorter life expectancy (Jylhä et al.”
Background
CRP gene variation affects early development of Alzheimer's disease-related plaques
Kok, E., Alanne-Kinnunen, M., Isotalo, K., Luoto, T., Haikonen, S., Goebeler, S., Perola, M., Hurme, M. A., Haapasalo, H., & Karhunen, P. J. (2011) · Journal of Neuroinflammation · doi:10.1186/1742-2094-8-96 · Cited by 16
“New research [12-14] supports this, as many inflammatory markers have been found localised with the neuropathological characteristics of AD; these include neuroinflammatory cells, astrocytes, and microglia.”
Background
Neuronostatin promotes soluble Aβ1-42 oligomers –induced spatial learning and memory impairments in mice
Yang, S., Shao, T., Yu, P., Cao, R., Zhang, M., Wen, K., Fan, M., & He, B. (2019) · Behavioural Brain Research · doi:10.1016/j.bbr.2019.01.047 · Cited by 16
“The patient suffering from AD are known to have abnormal deposition of Aβ42, which cause the activation of microglia and astrocytes, leading to neuronal damage via direct or indirect toxic effects [15].”
Oleoylethanolamide Treatment Modulates Both Neuroinflammation and Microgliosis, and Prevents Massive Leukocyte Infiltration to the Cerebellum in a Mouse Model of Neuronal Degeneration
Pérez-Martín, E., Pérez-Revuelta, L., Barahona-López, C., Pérez-Boyero, D., Alonso, J. R., Díaz, D., & Weruaga, E. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24119691 · Cited by 16
Mutated Toll-like receptor 9 increases Alzheimer’s disease risk by compromising innate immunity protection
Cacace, R., Zhou, L., de Craen, E. H. V., Buist, A., Hoogmartens, J., Sieben, A., Cras, P. P., Vandenberghe, R. R., Deyn, P. P. D., Oehlrich, D., et al. (2023) · Molecular Psychiatry · doi:10.1038/s41380-023-02166-0 · Cited by 16
Long-term LPS systemic administration leads to memory impairment and disturbance in astrocytic homeostasis
Schirmbeck, G. H., Seady, M., Fróes, F. T., Taday, J., Ré, C. D., Souza, J. M., Gonçalves, C. A., & Leite, M. C. (2023) · NeuroToxicology · doi:10.1016/j.neuro.2023.11.009 · Cited by 18
The influence of the commensal and pathogenic gut microbiota on prion disease pathogenesis
Donaldson, D. S., & Mabbott, N. A. (2016) · Journal of General Virology · doi:10.1099/jgv.0.000507 · Cited by 17
Interferons: A molecular switch between damage and repair in ageing and Alzheimer’s disease
Gorlé, N., & Vandenbroucke, R. E. (2019) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2019.111148 · Cited by 18
Targeting Inflammation, PHA-767491 Shows a Broad Spectrum in Protein Aggregation Diseases
Chung, Y.-H., Lin, C.-W., Huang, H., Chen, S.-L., Huang, H.-J., Sun, Y., Lee, G.-C., Lee‐Chen, G., Chang, Y.-C., & Hsieh‐Li, H. M. (2020) · Journal of Molecular Neuroscience · doi:10.1007/s12031-020-01521-y · Cited by 17
“In addition, studies suggest that peripheral inflammation and central inflammation are closely related (Kamer 2010).”
Background
Sleep Duration, Sleep Apnea, and Gray Matter Volume
Kim, R. E. Y., Abbott, R. D., Kim, S., THOMAS, R. J., Yun, C., Kim, H., Johnson, H. J., & Shin, C. (2021) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/0891988720988918 · Cited by 16
Identification and Analysis of BCAS4/hsa-miR-185-5p/SHISA7 Competing Endogenous RNA Axis in Late-Onset Alzheimer’s Disease Using Bioinformatic and Experimental Approaches
Sabaie, H., Talebi, M., Gharesouarn, J., Asadi, M. R., Jalaiei, A., Arsang‐Jang, S., Hussen, B. M., Taheri, M. N., Khoshnoud, R. J., & Rezazadeh, M. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.812169 · Cited by 15
“Furthermore, the peripheral level of inflammation-associated cytokines varies throughout the pathogenesis of AD and is substantially associated with disease development (Motta et al., 2007; Holmes et al., 2009; Leung et al., 2013).”
Background
The Role of Immunity in Alzheimer's Disease
McManus, R. M. (2022) · Advanced Biology · doi:10.1002/adbi.202101166 · Cited by 16
Alzheimer's Disease: Fatty Acids We Eat may be Linked to a Specific Protection via Low-dose Aspirin.
Pomponi, M. F. L., Gambassi, G., Pomponi, M., & Masullo, C. (2010) · Europe PMC (PubMed Central) · Cited by 15
Bombycis excrementum Reduces Amyloid-β Oligomer-Induced Memory Impairments, Neurodegeneration, and Neuroinflammation in Mice
Moon, M., Choi, J. G., Kim, S. Y., & Oh, M. S. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-140270 · Cited by 16
No relationship between lipoprotein-associated phospholipase A2, proinflammatory cytokines, and neopterin in Alzheimer's disease
Savaş, S., Kabaroğlu, C., Alpman, A., Saraç, F., Yalcin, M. A., Parıldar, Z., Özkınay, F., Kumral, E., & Akçiçek, F. (2016) · Experimental Gerontology · doi:10.1016/j.exger.2016.01.014 · Cited by 16
“In a prospective cohort study of patients with mild to severe AD, high baseline levels of TNF-α were associated with an increase in the rate of cognitive decline (Holmes et al., 2009).”
Background
Perspective: Is therapeutic plasma exchange a viable option for treating Alzheimer's disease?
Imbimbo, B. P., Ippati, S., Ceravolo, F., & Watling, M. (2020) · Alzheimer s & Dementia Translational Research & Clinical Interventions · doi:10.1002/trc2.12004 · Cited by 16
Treating inflammation in childhood neurodegenerative disorders
Lim, M. J. (2011) · Developmental Medicine & Child Neurology · doi:10.1111/j.1469-8749.2010.03902.x · Cited by 16
“Because childhood infections are very common, attempts to manage systemic inflammation may prove beneficial in modifying the rate of CNS disease progression in these conditions, again with promising parallels in adult neurodegeneration.(64) Irregularities in the immune system are also evident in a range of these neuro…”
Background
Sleep Disordered Breathing and Neurocognitive Disorders
Ogbu, I. R., Menon, T., Chahil, V., Kahlon, A., Devanand, D., & Kalra, D. K. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13175001 · Cited by 19
Biological determinants of blood-based biomarker levels in Alzheimer’s disease: role of nutrition, inflammation, and metabolic factors
Inamdar, A., Bugadannavar, P., Palled, M. S., Umarani, S., Salve, P. S., Gurupadayya, B., Patil, P. D., & Sharma, H. (2025) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2025.1614962 · Cited by 21
Exosomes in Age-Related Cognitive Decline: Mechanistic Insights and Improving Outcomes
Duggan, M. R., Lu, A., Foster, T. C., Wimmer, M. E., & Parikh, V. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.834775 · Cited by 15
SARS-CoV-2, long COVID, prion disease and neurodegeneration
Zhao, Y., Jaber, V. R., & Lukiw, W. J. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.1002770 · Cited by 16
Digital oral health biomarkers for early detection of cognitive decline
Chung, P.-C., & Chan, T. (2023) · BMC Public Health · doi:10.1186/s12889-023-16897-w · Cited by 15
“93, above moderate-level reliability [39].”
Mind the Gap: Unraveling the Intricate Dance Between Alzheimer’s Disease and Related Dementias and Bone Health
Karnik, S. J., Margetts, T. J., Wang, H. S., Movilă, A., Oblak, A. L., Fehrenbacher, J. C., Kacena, M. A., & Plotkin, L. I. (2024) · Current Osteoporosis Reports · doi:10.1007/s11914-023-00847-x · Cited by 15
“Conversely, systemic inflammation ensuing from osteoporosis and fractures could augment neuroinflammation and further propagate ADRD pathology [7, 39, 86, 122–124].”
Senoinflammation as the underlying mechanism of aging and its modulation by calorie restriction
Noh, S. G., Kim, H., Kim, S., Chung, K. W., Jung, Y.-S., Yoon, J.-H., Yu, B. P., Lee, J., & Chung, H. Y. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102503 · Cited by 16
Challenges in Gaucher disease: Perspectives from an expert panel
Grabowski, G. A., Kishnani, P. S., Alcalay, R. N., Prakalapakorn, S. G., Rosenbloom, B. E., Tuason, D. A., & Weinreb, N. J. (2025) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2025.109074 · Cited by 17
Is Alzheimer disease a failure of mobilizing immune defense? Lessons from cognitively fit oldest-old
Katsel, P., & Haroutunian, V. H. (2019) · Phlebolymphology · doi:10.31887/dcns.2019.21.1/vharoutunian · Cited by 14
Accelerated onset of CNS prion disease in mice co-infected with a gastrointestinal helminth pathogen during the preclinical phase
Donaldson, D. S., Bradford, B. M., Else, K. J., & Mabbott, N. A. (2020) · Scientific Reports · doi:10.1038/s41598-020-61483-4 · Cited by 14
Osteoarthritis Was Associated With a Faster Decline in Hippocampal Volumes in Cognitively Normal Older People
Li, X., Tong, Q., Gao, J., Liu, C., Initiative, A. D. N., & Liu, Y. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.00190 · Cited by 16
“Additionally, levels of several proinflammatory cytokines in serum were found to be associated with the risk of AD dementia (Tan et al., 2007; Holmes et al., 2009).”
Background
Intranasal Delivery: Effects on the Neuroimmune Axes and Treatment of Neuroinflammation
Rhea, E. M., Logsdon, A. F., Banks, W. A., & Erickson, M. A. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12111120 · Cited by 15
“In addition, soluble TNF-αhas a saturable transport system at the BBB [144], and increased serum levels of TNF-αhave been associated with increased rates of cognitive decline in AD patients [145].”
Background
Anti-Inflammatory Agents: An Approach to Prevent Cognitive Decline in Alzheimer’s Disease
Brod, S. A. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-215125 · Cited by 16
“:3) predicted a fourfold increase in the rate of cognitive decline [40].”
Sleep duration and biomarkers of inflammation in African American and white participants with a parental history of Alzheimer's disease
Pak, V. M., Paul, S., Swieboda, D., Balthazar, M. S., & Wharton, W. (2022) · Alzheimer s & Dementia Translational Research & Clinical Interventions · doi:10.1002/trc2.12332 · Cited by 13
Increased expression of Interleukin-18 receptor in blood cells of subjects with Mild Cognitive Impairment and Alzheimer’s disease
Salani, F., Ciaramella, A., Bizzoni, F., Assogna, F., Caltagirone, C., Spalletta, G., & Bossù, P. (2012) · Cytokine · doi:10.1016/j.cyto.2012.11.001 · Cited by 15
“Albeit inflammation-related brain damage is postulated to be mainly due to activation of resident microglia, neurodegenerative changes in the brain appear to be also associated with changes in the peripheral immune system [3,4].”
Alzheimer’s disease and infections, where we stand and where we go
Monastero, R., Caruso, C., & Vasto, S. (2014) · Immunity & Ageing · doi:10.1186/s12979-014-0026-4 · Cited by 16
“Accordingly, acute episodes of systemic inflammation with increased levels of inflammatory mediator tumor necrosis factor-alpha, which are associated with AD [5], have been shown to be associated with long-term cognitive decline in a prospective cohort study of subjects with AD [16].”
Background
Revisión de las novedades presentadas en el XXVI Congreso del Comité Europeo para el Tratamiento e Investigación en Esclerosis Múltiple (ECTRIMS) (I)
Fernández, O. R., Cermeño, J. C. Á., Urdiain, T. A., González, R. V. A., García, C. A., Casanova-Estruch, B., Hernández, M. C. C., Ferrer, F. C., Comabella, M., Merino, J. A. G., et al. (2011) · Revista de Neurología · doi:10.33588/rn.5204.2010782 · Cited by 15
Effective Targeting of Aβ to Macrophages by Sonochemically Prepared Surface-Modified Protein Microspheres
Richman, M., Perelman, A., Gertler, A. A., & Rahimipour, S. (2012) · Biomacromolecules · doi:10.1021/bm301401b · Cited by 15
Gene expression in the aging human brain
Mohan, A., Mather, K. A., Thalamuthu, A., Baune, B. T., & Sachdev, P. S. (2016) · Current Opinion in Psychiatry · doi:10.1097/yco.0000000000000238 · Cited by 16
“Immune system activation in aging can be conceptualized both as a risk ‘state’ priming the brain for the subsequent development of neurodegenerative disease, and an event downstream of pathoplastic processes [15].”
Background
An Association Study of 21 Potential Alzheimer's Disease Risk Genes in a Finnish Population
Sarajärvi, T., Helisalmi, S., Antikainen, L., Mäkinen, P. M., Koivisto, A. M., Herukka, S., Haapasalo, A., Soininen, H. S., & Hiltunen, M. O. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-100597 · Cited by 15
The neuroinflammatory marker sTNFR2 relates to worse cognition and tau in women across the Alzheimer's disease spectrum
Bernier, R. A., Banks, S. J., Panizzon, M. S., Andrews, M., Jacobs, E. G., Galasko, D. R., Shepherd, A. L., Akassoglou, K., Sundermann, E. E., & Initiative, A. D. N. (2022) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1002/dad2.12284 · Cited by 13
“The lower technical limit to upper technical limit for the Elecsys b-Amyloid (1-42) CSF immunoassay was 200 to 1700 pg/mL.”
Background
Methylprednisolone alleviates cognitive functions through the regulation of neuroinflammation in Alzheimer’s disease
Sun, Y., Li, J., Nan, A., Li, Z., Zhong, W., Chen, L., Liu, S., Zhang, B., Zhu, Z., & Li, X. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1192940 · Cited by 13
“Increased levels of proinflammatory cytokines are associated with an increasing rate of cognitive decline in patients with AD (13).”
Background
Recent Trends in Active and Passive Immunotherapies of Alzheimer’s Disease
Alshamrani, M. (2023) · Antibodies · doi:10.3390/antib12020041 · Cited by 17
Experimental colitis in young Tg2576 mice accelerates the onset of an Alzheimer’s-like clinical phenotype
Lorenzini, L., Zanella, L., Sannia, M., Baldassarro, V. A., Moretti, M., Cescatti, M., Quadalti, C., Baldi, S., Bartolucci, G., Gloria, L. D., et al. (2024) · Alzheimer s Research & Therapy · doi:10.1186/s13195-024-01471-2 · Cited by 15
“A large body of evidence indicates a relationship between systemic inflammation, neuroinflammation and AD [7], based on the assumption that a dysregulated immune response is a cardinal feature of AD [8].”
Background
One immune cell to bind them all: platelet contribution to neurodegenerative disease
Moore, G. R., Melo-Escobar, I., Stegner, D., & Bracko, O. (2024) · Molecular Neurodegeneration · doi:10.1186/s13024-024-00754-4 · Cited by 18
Could Nutrition Prevent the Onset of dementia? Current Evidence From Epidemiological and Intervention Studies
Barberger‐Gateau, P., Samieri, C., Allès, B., & Féart, C. (2012) · Neurodegenerative Disease Management · doi:10.2217/nmt.12.24 · Cited by 14
The Role of Aging in Alzheimer’s Disease
Kerchner, G. A., & Wyss‐Coray, T. (2015) · Springer eBooks · doi:10.1007/978-3-319-23246-1_7 · Cited by 14
TNFα affects CREB-mediated neuroprotective signaling pathways of synaptic plasticity in neurons as revealed by proteomics and phospho-proteomics
Jensen, P., Myhre, C. L., Lassen, P. S., Metaxas, A., Khan, A. M., Lambertsen, K. L., Babcock, A. A., Finsen, B. R., Larsen, M. R., & Kempf, S. J. (2017) · Oncotarget · doi:10.18632/oncotarget.19428 · Cited by 14
“Systemic inflammation leading to increased TNFα is associated with disease progression/ cognitive decline in AD patients [2], and systemic challenge, such as administration of lipopolysaccharide (LPS), can provoke waves of TNFα expression in the rodent brain [3].”
Background
Putative Involvement of Endocrine Disruptors in the Alzheimer's Disease Via the Insulin-Regulated Aminopeptidase/GLUT4 Pathway
Ramírez-Expósito, M. J., Martínez-Martos, J. M., Cantón-Habas, V., & Carrera-González, M. P. (2020) · Current Neuropharmacology · doi:10.2174/1570159x18666201111103024 · Cited by 17
“TNF-α, a pro-inflammatory cytokine, as we have shown above, is involved in the mechanism of insulin resistance and is a common component of inflammatory signalling in AD [80] and DMTII and obesity [81] (Fig.”
Background
The role of peripheral fatty acids as biomarkers for Alzheimer's disease and brain inflammation
Cisbani, G., & Bazinet, R. P. (2020) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2020.102205 · Cited by 14
Fighting fire with fire: The immune system might be key in our fight against Alzheimer’s disease
Dujardin, P., Vandenbroucke, R. E., & Hoecke, L. V. (2022) · Drug Discovery Today · doi:10.1016/j.drudis.2022.01.004 · Cited by 14
Albumin and Hemoglobin Trajectories and Incident Disabling Dementia in Community-Dwelling Older Japanese
Taniguchi, Y., Kitamura, A., Kaito, S., Yokoyama, Y., Yokota, I., Shinozaki, T., Seino, S., Murayama, H., Matsuyama, Y., Ikeuchi, T., et al. (2019) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000499837 · Cited by 14

Authors: Holmes, C., Cunningham, C., Zotova, E., Woolford, J., Dean, C., Kerr, S., Culliford, D., & Perry, V. H.
Affiliations: Trinity College Dublin (IE)
ORCID: Holmes, C.
Cunningham, C.
Culliford, D.
Perry, V. H.
Venue: Neurology
Publisher: Ovid Technologies (Wolters Kluwer Health)
Published: 2009-09-08
Volume: 73
Issue: 10
Pages: 768-774
ISSN: 0028-3878 (ISSN-L)
1526-632X
DOI: 10.1212/wnl.0b013e3181b6bb95
PMC: PMC2848584
OpenAlex: W2085558085
Semantic Scholar: cbac9326b978c2365dec0a3f265816a795105bb1
Cited by: 1,139
References: 42
Citations by year: 2026: 48 · 2025: 68 · 2024: 85 · 2023: 75 · 2022: 77 · 2021: 87 · 2020: 84 · 2019: 89 · 2018: 71 · 2017: 71 · 2016: 59 · 2015: 67 · 2014: 57 · 2013: 55 · 2012: 58
FWCI: 29.59
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Locations: Neurology (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
ePrints Soton (University of Southampton) (submittedVersion)
Funders: Wellcome Trust (078300)
National Institute for Health and Care Research
National Institutes of Health (5rc2ag036502-02)
Biotechnology and Biological Sciences Research Council
National Institute on Aging (R01AG012101)
Topics: Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Keywords: Alzheimer's disease, systemic inflammation, TNF-α, cognitive decline, disease progression, neuroinflammation, microglial activation, inflammatory cytokines, serum biomarkers
MeSH terms: Acute Disease, Aged, Aged, 80 and over, Alzheimer Disease, Chronic Disease, Cognition Disorders, Female, Follow-Up Studies, Humans, Male, Prospective Studies, Retrospective Studies, Tumor Necrosis Factor-alpha, Cohort Studies, Biomarkers, Disease Progression, Inflammation Mediators

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Systemic inflammation and disease progression in Alzheimer disease

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks